Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials

Core Insights - Science 37 has been added to over 20 studies that were lagging in recruitment, helping them to trend back towards their projected targets [1] - The company leverages its proprietary Virtual Site and Patient Recruitment solutions to efficiently identify, recruit, medically qualify, and enroll patients without geographic restrictions [1][6] - Science 37's mission is to accelerate clinical research by enabling universal trial access for patients [6] Company Solutions - Science 37 provides Patient Recruitment as a standalone service or in combination with its flagship Virtual Site, the Metasite™, to enhance patient enrollment efforts [5] - The company has successfully supplemented enrollment in various studies, including Phase 2 through Phase 4 and Observational trials across multiple therapeutic areas such as Hematology, Hepatology, Infectious Diseases, CNS, Oncology, and Rare Diseases [2] - The solutions are powered by a proprietary technology stack with in-house medical and operational experts, enhancing quality through standardized workflows and best-in-class study orchestration [6]